We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+18.46%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$252B
AUM Growth
+$44.2B
Cap. Flow
+$8.62B
Cap. Flow %
3.42%
Top 10 Hldgs %
18.97%
Holding
7,231
New
391
Increased
2,898
Reduced
2,887
Closed
391

Sector Composition

Rank Sector Weight
1 Financials 17.91%
2 Technology 12.06%
3 Healthcare 8.48%
4 Communication Services 7.49%
5 Industrials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRAW icon
6851
Traws Pharma
TRAW
$8.12M
$0 ﹤0.01%
1
GRDX
6852
GridAI Technologies Corp
GRDX
$23.3M
0
QCLS
6853
Q/C Technologies Inc
QCLS
$22.7M
0
GAP
6854
CALL
The Gap Inc
GAP
$7.29B
-265,000
Closed -$1.87M
GAP
6855
PUT
The Gap Inc
GAP
$7.29B
-765,000
Closed -$5.39M
IRD
6856
Opus Genetics
IRD
$313M
$0 ﹤0.01%
5
ACCS
6857
ACCESS Newswire
ACCS
$20M
$0 ﹤0.01%
5
NAGE
6858
Niagen Bioscience
NAGE
$242M
$0 ﹤0.01%
83
-130
-61% -$582
TGEN
6859
Tecogen Inc
TGEN
$120M
-738
Closed -$1K
PAVMZ
6860
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$0 ﹤0.01%
200
CMRX
6861
DELISTED
Chimerix, Inc.
CMRX
$0 ﹤0.01%
84
-18,306
-100% -$47.4K
IVAC
6862
DELISTED
Intevac Inc
IVAC
-1,500
Closed -$6K
EGF
6863
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$0 ﹤0.01%
1
BCOW
6864
DELISTED
1895 Bancorp of Wisconsin
BCOW
-132
Closed -$1K
BEST
6865
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
-270
Closed -$27.7K
BCOV
6866
DELISTED
Brightcove, Inc.
BCOV
$0 ﹤0.01%
44
-165
-79% -$1.33K
LFLYW
6867
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$0 ﹤0.01%
+24
New +$12
PFIE
6868
DELISTED
Profire Energy, Inc
PFIE
$0 ﹤0.01%
208
-9,901
-98% -$8.21K
PMD
6869
DELISTED
Psychemedics Corporation
PMD
$0 ﹤0.01%
5
TFFP
6870
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
-200
Closed -$19K
VCNX
6871
DELISTED
Vaccinex, Inc. Common Stock
VCNX
0
TDW.WS
6872
DELISTED
Tidewater Inc.
TDW.WS
-20
Closed
PIXY
6873
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
0
-$5K
ORGS
6874
DELISTED
Orgenesis Inc. Common Stock
ORGS
-12
Closed
SEEL
6875
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0

Similar funds

Royal Bank of Canada's Q2 2020 Portfolio in Review

As of Q2 2020, Royal Bank of Canada held 7,231 positions worth $252B, up 21% from $208B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada deployed $8.62B of net new capital in Q2 2020, opening 391 new positions and adding to 2,898 existing holdings. Its largest new stake was Otis Worldwide: 1,329,741 shares worth $75.6M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $582M trimmed.

  • Royal Bank of Canada's largest Q2 2020 buy was Otis Worldwide: 1,329,741 shares worth $75.6M.
  • Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $640M increase.
  • Royal Bank of Canada's biggest Q2 2020 reduction was iShares MSCI EAFE ETF, cutting an estimated $582M.
  • Royal Bank of Canada fully exited Allergan plc in Q2 2020, selling an estimated $234M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $252B portfolio in Q2 2020.
  • Royal Bank of Canada opened 391 new positions and closed 391 in Q2 2020.
  • Royal Bank of Canada's portfolio value rose 21% quarter-over-quarter to $252B.

Based on Royal Bank of Canada's 13F filing for Q2 2020, filed 14 Aug 2020.